FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Healthcare Real Estate: Responding to Shifting Patient Demands

To compete in a changing landscape, healthcare organizations must turn their real estate from a cost center into a competitive advantage.

Over 40% of Workers Impacted by Seasonal Depression

Seasonal changes can have an impact on work performance.

Archer Property Partners Acquires Medical Office Building Near Tri-City Hospital

Archer plans a $2.5 million capital improvement program to fully modernize and reposition the asset as one of North County’s premier medical office destinations.

The OR HVAC Puzzle: Why Individual Systems Are on the Rise

Extra penetrations, tight clearances and strict humidity needs—design experts explain what it really takes to plan dedicated units for each operating room.

Sutter Health Announces Plans for New Santa Clara Medical Center

Sutter projects the medical center will open in late 2031.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.